Rubico Inc. Announces Time Charter Extensions and Contracted Revenue Backlog of $120.8 Million

(NASDAQ:RUBI), ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (NASDAQ: RUBI) (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today that it entered into agreements with the time charterer of both its vessels to extend their time charter employment. Specifically, both vessels will continue earning a […]

Purespring Therapeutics to Present at Piper Sandler’s 37th Annual Healthcare Conference

Purespring Therapeutics to Present at Piper Sandler's 37th Annual Healthcare Conference London – 25 November 2025 – Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function, today announced that members of its management team will present at Piper Sandler's 37th Annual Healthcare Conference being held December

Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update

AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing a major clinical challenge in acute myeloid leukaemia (AML) AMX-883 showed a significant survival benefit and reduced disease burden compared to control treatments, while being well tolerated in a murine pre-clinical experiment Data provides

Accessibility Resource on Approaching Section 508 Compliance Released by Digital Silk

Digital Silk, an award-winning digital agency focused on creating brand strategies, custom websites, and digital marketing campaigns, announces the publication of a new article offering insights on how organizations can approach building Section 508 compliant websites. The piece outlines practical considerations that may support accessibility efforts for federal agencies, contractors, and businesses aiming to meet

Calumet to Attend Bank of America Leveraged Finance Conference

Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today that it plans to attend the Bank of America Leveraged Finance Conference on Tuesday, December 2nd and will hold one-on-one investor meetings throughout the day. About Calumet Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across

Ardagh Group – Retirement of CFO

Ardagh Group S.A. (Ardagh) announces that John Sheehan will step down as Group CFO at current year end, as signalled to the Board earlier this year. A process is under way to appoint a successor, and a further announcement will be made in due course. https://mma.prnewswire.com/media/2831309/Ardagh_Group_Logo.jpg Commenting, Mark Porto, Executive Chairman, Ardagh said “We are

Ardagh Group Third Quarter 2025 Results

Ardagh Group S.A. today reports its Third Quarter 2025 Interim Financial Report. https://mma.prnewswire.com/media/2831309/Ardagh_Group_Logo.jpg A copy of the Interim Report can be found on our website: https://www.ardaghgroup.com/investors A bondholder webcast and conference call will be held at 13:00 GMT (08:00 EST) on November 25, 2025. A full replay of the presentation will also be available at

In Response to Inquiries from London Press, Fermi America™ Confirms Company in Discussions for $4+ Billion in Project Financing for First Tenant

In response to inquiries from London press,Fermi America™, (Nasdaq: FRMI)(LSE: FRMI) today confirmed the company is in discussions for $4+ billion in project financing for its first tenant. https://mma.prnewswire.com/media/2831647/FERMI_AMERICA__Fermi_Water_Pipe.jpg The project financing is projected to be non-recourse financing through a special purpose vehicle (SPV). For media inquiries, please contact:Lexi SwearingenMedia@FermiAmerica.com About Fermi AmericaFermi America™ (Nasdaq:

The J.M. Smucker Co. Announces Fiscal 2026 Second Quarter Results

The J.M. Smucker Co. (NYSE: SJM) today announced results for the second quarter ended October 31, 2025, of its 2026 fiscal year. Financial results for the second quarter of fiscal year 2026 reflect the divestiture of certain Sweet Baked Snacks value brands on March 3, 2025, and the divestiture of theVoortman® business on December 2,

Bio-Techne to Present at Upcoming Investor Conferences

Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 8th Annual Evercore Healthcare Conference 2025December 2, 20258:20 AM EST Citi's 2025 Global Healthcare ConferenceDecember 3, 20253:15 PM EST 53rd Annual Nasdaq Investor ConferenceDecember 9, 20259:30 AM GMT A live webcast of the presentations can be accessed via the IR

Scroll to Top